Cecelia Damask
YOU?
Author Swipe
View article: Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary Workshop
Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary Workshop Open
Allergic fungal rhinosinusitis (AFRS) is a unique endotype of chronic rhinosinusitis with nasal polyps (CRSwNP). Despite high recurrence rates and often more severe presenting signs compared with other subtypes of CRSwNP, research dedicate…
View article: Clinical Practice Guideline: Immunotherapy for Inhalant Allergy
Clinical Practice Guideline: Immunotherapy for Inhalant Allergy Open
Objective Allergen immunotherapy (AIT) is the therapeutic exposure to an allergen or allergens selected by clinical assessment and allergy testing to decrease allergic symptoms and induce immunologic tolerance. Inhalant AIT is administered…
View article: Plain Language Summary: Immunotherapy for Inhalant Allergy
Plain Language Summary: Immunotherapy for Inhalant Allergy Open
The plain language summary explains allergen immunotherapy to patients, families, and caregivers. The summary is for patients aged 5 years and older who are experiencing symptoms from inhalant allergies and are considering immunotherapy as…
View article: Issue Information
Issue Information Open
View article: Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy
Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy Open
Objective Allergen immunotherapy (AIT) is the therapeutic exposure to an allergen or allergens selected by clinical assessment and allergy testing to decrease allergic symptoms and induce immunologic tolerance. Inhalant AIT is administered…
View article: International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023 Open
Background In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐A…
View article: Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study Open
Background Although the psychometric properties of patient-reported outcome measures (e.g. the 22-item Sino-nasal Outcomes Test [SNOT-22]) in chronic rhinosinusitis with nasal polyps (CRSwNP) have been defined, these definitions have not b…
View article: Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial Open
View article: Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) Executive Summary
Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) Executive Summary Open
Objective This guideline provides evidence‐based recommendations on treating patients presenting with dysphonia, which is characterized by altered vocal quality, pitch, loudness, or vocal effort that impairs communication and/or quality of…
View article: Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)
Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) Open
Objective This guideline provides evidence‐based recommendations on treating patients who present with dysphonia, which is characterized by altered vocal quality, pitch, loudness, or vocal effort that impairs communication and/or quality o…
View article: International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis Open
Background Critical examination of the quality and validity of available allergic rhinitis (AR) literature is necessary to improve understanding and to appropriately translate this knowledge to clinical care of the AR patient. To evaluate …
View article: 国际过敏与鼻科学共识声明 : 变应性鼻炎
国际过敏与鼻科学共识声明 : 变应性鼻炎 Open
S.108-352